Loading stock data…
Loading stock data…
US$0.50
Get one email when CTXR crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-2.88%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
36.6
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.02
Bearish momentumMACD below its signal line (-0.02).
50-day average
0.59
Price belowShort-term trend reference.
200-day average
0.90
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company specializing in the development and commercialization of first-in-class critical care products. The company focuses on innovative therapies primarily in anti-infectives, oncology, adjunct cancer care, stem cell therapy, and unique prescription products. Its diverse pipeline includes candidates targeting serious medical conditions, reflecting a commitment to advancing treatments that address critical unmet needs in healthcare.…
citiuspharma.com2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-16 | 1.65 | 1.67 | ✓ Beat |
| 2026-05-15 | -0.32 | -0.95 | ✗ Miss |
| 2026-04-14 | 0.44 | 0.48 | ✓ Beat |
| 2026-02-06 | 3.18 | 6.15 | ✓ Beat |
| 2025-12-23 | -0.24 | -0.11 | ✓ Beat |
| 2025-09-29 | -0.18 | -0.11 | ✓ Beat |
| 2025-08-12 | -0.21 | -0.8 | ✗ Miss |
Companies in the same industry, via Finnhub